News and Press Releases
updates on the latest developments at febit
Take the opportunity to be amongst the first to get updates on the latest developments at febit by joining our mailing list for journalists. Feel free to contact us if you are missing any kind of information on these pages.
Contact febit: pr@febit.de
-
June 23, 2010
febit Announces Operational Restructuring
Strategic focus on partnerships with clinical researchers, diagnostic and pharma industry for its microRNA (miRNA) biomarker technology
-
June 15, 2010
Blood-borne microRNA signatures as specific biomarkers for melanoma
New study supported by febit now published in BMC Cancer
-
June 7, 2010
MicroRNA Signatures Show Promising Potential as Biomarkers for Broad Range of Diseases
Presentation of novel microRNA biomarkers at the ESHG 2010
-
May 7, 2010
Exclusively from febit: the miRBase 15 plus Biochip
Contains the brandnew miRBase 15 plus 50 additional human miRNA sequences.
-
April 27, 2010
Second Biomarker Expert Meeting in Heidelberg
Novel biomarkers enable innovative approaches in diagnostics and therapy for cancer and cardiovascular diseases
-
April 26, 2010
febit first to offer miRNA microarrays based on miRBase 15
The release 15 of the database represents a significant update. It contains over 3000 new hairpin sequences and more than 4000 new mature sequences.
Im Neuenheimer Feld 519
69120 Heidelberg
Germany
- Phone:
- +49 (0)6221 - 6510-300
- Fax:
- +49 (0)6221 - 6510-329
- E-mail:
- info@febit.eu
Americas febit inc.
99 Hayden Ave
Suite 620
Lexington, MA 02421
USA
- Phone:
- +1 781 - 391 - 4360
- Toll free
- (877 - Geniom1)*
- or 877 - 436 - 4661
- Fax:
- +1 781 - 391 - 4362
- E-mail:
- info@febit.com
*Note: This number is only toll-free for callers inside of the US and Canada
